Literature DB >> 1526021

Identification of the steroids in neonatal plasma that interfere with 17 alpha-hydroxyprogesterone radioimmunoassays.

T Wong1, C H Shackleton, T R Covey, G Ellis.   

Abstract

Neonatal plasma contains interferents that increase the apparent 17 alpha-hydroxyprogesterone (17-OHP) content measured by direct (no-extraction) radioimmunoassay. We fractionated extracts from neonatal plasma pools by liquid chromatography with a Sephadex LH-20 column and measured 17-OHP immunoreactivity by a direct test kit. We found immunoreactivity in the free steroid and glucuronide fraction and also in the monosulfate fraction. We analyzed these two fractions by reversed-phase high-performance liquid chromatography (HPLC) and HPLC-mass spectrometry. We collected fractions and assayed for 17-OHP immunoreactivity. The HPLC fractions containing the interfering steroid monosulfates were analyzed by ion-spray mass spectrometry and, after solvolysis, by gas chromatography-mass spectrometry. Several monosulfates were identified, including those of 17 alpha-hydroxy-pregnenolone, 16 alpha-hydroxypregnenolone, pregnenolone, and several pregnenetriols. 17 alpha-Hydroxypregnenolone sulfate was the most significant interferent. Other commercially available 17-OHP assays showed similar interference when used without an extraction step. Kit manufacturers should select antibodies and protocols to minimize cross-reaction with sulfates, especially 17 alpha-hydroxypregnenolone sulfate.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1526021

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  21 in total

1.  Rapid screening assay of congenital adrenal hyperplasia by measuring 17 alpha-hydroxyprogesterone with high-performance liquid chromatography/electrospray ionization tandem mass spectrometry from dried blood spots.

Authors:  Chien-Chen Lai; Chang-Hai Tsai; Fuu-Jen Tsai; Jer-Yuarn Wu; Wei-De Lin; Cheng-Chun Lee
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

Review 2.  Holistic management of DSD.

Authors:  Caroline E Brain; Sarah M Creighton; Imran Mushtaq; Polly A Carmichael; Angela Barnicoat; John W Honour; Victor Larcher; John C Achermann
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2010-04       Impact factor: 4.690

3.  Heat-map visualization of gas chromatography-mass spectrometry based quantitative signatures on steroid metabolism.

Authors:  Ju-Yeon Moon; Hyun-Jin Jung; Myeong Hee Moon; Bong Chul Chung; Man Ho Choi
Journal:  J Am Soc Mass Spectrom       Date:  2009-05-05       Impact factor: 3.109

Review 4.  Neonatal screening for congenital adrenal hyperplasia.

Authors:  Perrin C White
Journal:  Nat Rev Endocrinol       Date:  2009-09       Impact factor: 43.330

5.  Simultaneous quantitation of 17alpha-hydroxyprogesterone caproate, 17alpha-hydroxyprogesterone and progesterone in human plasma using high-performance liquid chromatography-mass spectrometry (HPLC-MS/MS).

Authors:  Shimin Zhang; Sripal Reddy Mada; Shringi Sharma; Marilyn Torch; Don Mattison; Steve Caritis; Raman Venkataramanan
Journal:  J Pharm Biomed Anal       Date:  2008-08-29       Impact factor: 3.935

6.  Reduction of the false-positive rate in newborn screening by implementation of MS/MS-based second-tier tests: the Mayo Clinic experience (2004-2007).

Authors:  D Matern; S Tortorelli; D Oglesbee; D Gavrilov; P Rinaldo
Journal:  J Inherit Metab Dis       Date:  2007-07-23       Impact factor: 4.982

Review 7.  Improving Laboratory Assessment in Disorders of Sex Development through a Multidisciplinary Network.

Authors:  Sabine E Hannema; Yolanda B de Rijke
Journal:  Sex Dev       Date:  2018-01-17       Impact factor: 1.824

8.  Successful prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  S A Wudy; J Homoki; W M Teller
Journal:  Eur J Pediatr       Date:  1994-08       Impact factor: 3.183

9.  Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline.

Authors:  Phyllis W Speiser; Wiebke Arlt; Richard J Auchus; Laurence S Baskin; Gerard S Conway; Deborah P Merke; Heino F L Meyer-Bahlburg; Walter L Miller; M Hassan Murad; Sharon E Oberfield; Perrin C White
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

Review 10.  Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.

Authors:  Hedi L Claahsen-van der Grinten; Phyllis W Speiser; S Faisal Ahmed; Wiebke Arlt; Richard J Auchus; Henrik Falhammar; Christa E Flück; Leonardo Guasti; Angela Huebner; Barbara B M Kortmann; Nils Krone; Deborah P Merke; Walter L Miller; Anna Nordenström; Nicole Reisch; David E Sandberg; Nike M M L Stikkelbroeck; Philippe Touraine; Agustini Utari; Stefan A Wudy; Perrin C White
Journal:  Endocr Rev       Date:  2022-01-12       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.